Pharmacologic Treatment of Portal Hypertension.
Clin Liver Dis
; 28(3): 417-435, 2024 Aug.
Article
in En
| MEDLINE
| ID: mdl-38945635
ABSTRACT
Portal hypertension is the key mechanism driving the transition from compensated to decompensated cirrhosis. In this review, the authors described the pathophysiology of portal hypertension in cirrhosis and the rationale of pharmacologic treatment of portal hypertension. We discussed both etiologic and nonetiologic treatment of portal hypertension and the specific clinical scenarios how nonselective beta-blocker can be used in patients with cirrhosis. Finally, the authors summarized the evidence for emerging alternatives for portal hypertension in patients with cirrhosis.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adrenergic beta-Antagonists
/
Hypertension, Portal
/
Liver Cirrhosis
Limits:
Humans
Language:
En
Journal:
Clin Liver Dis
Journal subject:
GASTROENTEROLOGIA
Year:
2024
Document type:
Article
Affiliation country: